logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-02-26 ENANTA PHARMACEUTICALS INC Gardiner Nathanie...
(Chief Legal Officer)
M Common Stock A 5187 $8.99 - $8.99 $46,631
2024-02-12 ENANTA PHARMACEUTICALS INC Luu Brendan
(Chief Business Officer)
F Common Stock D 973 $12.41 - $12.41 $12,074
2024-02-12 ENANTA PHARMACEUTICALS INC Luu Brendan
(Chief Business Officer)
A Common Stock A 3320 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC Kieffer Tara Lynn
(Chief Product Strategy Officer)
F Common Stock D 973 $12.41 - $12.41 $12,074
2024-02-12 ENANTA PHARMACEUTICALS INC Kieffer Tara Lynn
(Chief Product Strategy Officer)
A Common Stock A 3320 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC Gardiner Nathanie...
(Chief Legal Officer)
F Common Stock D 973 $12.41 - $12.41 $12,074
2024-02-12 ENANTA PHARMACEUTICALS INC Gardiner Nathanie...
(Chief Legal Officer)
A Common Stock A 3320 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC Rottinghaus Scott T.
(Chief Medical Officer)
F Common Stock D 755 $12.41 - $12.41 $9,369
2024-02-12 ENANTA PHARMACEUTICALS INC Rottinghaus Scott T.
(Chief Medical Officer)
A Common Stock A 2576 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC Or Yat Sun
(Chief Scientific Officer)
F Common Stock D 1080 $12.41 - $12.41 $13,402
2024-02-12 ENANTA PHARMACEUTICALS INC Or Yat Sun
(Chief Scientific Officer)
A Common Stock A 3680 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC MELLETT PAUL J
(Chief Fin. & Admin Officer)
F Common Stock D 973 $12.41 - $12.41 $12,074
2024-02-12 ENANTA PHARMACEUTICALS INC MELLETT PAUL J
(Chief Fin. & Admin Officer)
A Common Stock A 3320 $0.00 - $0.00 $0
2024-02-12 ENANTA PHARMACEUTICALS INC Luly Jay R.
(President and CEO)
F Common Stock D 1584 $12.41 - $12.41 $19,657
2024-02-12 ENANTA PHARMACEUTICALS INC Luly Jay R.
(President and CEO)
A Common Stock A 5400 $0.00 - $0.00 $0
2023-12-13 ENANTA PHARMACEUTICALS INC Vance Terry
(Director)
S Common Stock D 15295 $9.12 - $9.12 $139,490
2023-12-05 ENANTA PHARMACEUTICALS INC Rottinghaus Scott T.
(Sr. VP & CMO)
S Common Stock D 534 $9.63 - $9.63 $5,142
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6